MedTech & Biotech

From lab to global market: what will it take for Poland to scale MedTech and Biotech?

Poland has strong scientific talent, engineering capabilities and a growing MedTech and biotech ecosystem. Yet turning research breakthroughs into globally competitive companies remains a major challenge. This panel will explore what Poland needs to improve across the entire innovation pathway — from university research and intellectual property to clinical validation, regulatory approval, investment and international expansion. Bringing together perspectives from government, academia, industry and venture capital, the discussion will identify the barriers that continue to slow down commercialisation and the practical changes needed to build globally scalable life-science companies in Poland.

• Panel

• Dr. Dagmara SłotaPK Krakow University of TechnologyDr. Dagmara SłotaKierownik projektu LIDER XIV (NCBR), Instytut Inżynierii Materiałowej, PK Krakow University of TechnologyDr Eng. Dagmara Słota is a researcher at PK Krakow University of Technology specialising in biomaterials for medical applications. Her research focuses on drug-delivery systems and advanced materials supporting bone and cartilage regeneration. Working at the intersection of materials science, biomedical engineering and translational medicine, she is particularly interested in turning scientific discoveries into technologies with clinical potential. She is the principal investigator of a LIDER project funded by the Polish National Centre for Research and Development (NCBR). She has also been honoured with the title of Young Promoter of Poland and recognised as one of the Top 10 Women in Engineering in Poland.Read full bio →
• Tomasz CiachWUMTomasz CiachProfessor, WUMProf. Tomasz Ciach is a scientist, engineer, and technology entrepreneur working at the interface of chemistry, nanotechnology, biotechnology, and medicine. He has an interdisciplinary background in chemical engineering and biology and heads the Biotechnology and Bioprocess Engineering Division at the Faculty of Chemical and Process Engineering, Warsaw University of Technology. His work focuses on the development of commercially relevant medical technologies, including drug delivery systems, nanoparticles, implants, synthetic oxygen carriers, and advanced biomaterials. Prof. Ciach combines academic research with strong translational and commercialization activity. Technologies developed by his teams have led to six products introduced to the medical market. He has also co-founded eight spin-off and spin-out companies created to bring advanced medical and biotechnology solutions from the laboratory to industry. He is the author of numerous scientific publications, an inventor on fifty patents and patent applications, and has been included in the Stanford University–Elsevier World’s Top 2% Scientists ranking.Read full bio →
• Maciej GołaszewskiBioCloner Health PolandMaciej GołaszewskiCTO, BioCloner Health PolandMaciej Gołaszewski is a board member and CTO of BioCloner Health, a Polish deep-tech company developing 3D bioprinters with fully in-house hardware, firmware and software. He is also a Business and Technology Advisor at Kulczyk Investments and a mentor in InCredibles, Sebastian Kulczyk's programme supporting innovators and technology entrepreneurs. A graduate of Warsaw University of Technology, he has published research on the mechanics of metamaterials and on bioprinting. Under his technical leadership, the BioCloner Desktop Pro bioprinter has been implemented at leading Polish universities and research institutes. He is now focused on expanding the company into the United States and serves as Director of BioCloner Health's U.S. subsidiary.Read full bio →
• Karolina JarosińskaExecMindKarolina JarosińskaFounder & Managing Director, ExecMindKarolina Jarosinska is Founder and Managing Director of ExecMind, a specialist Life Sciences executive search and talent advisory firm established in 2015. She partners with founders, boards and investors across Europe to build leadership teams that drive growth, execution and long-term value creation in biotech, biopharma and MedTech. With over 20 years in executive recruitment, over a decade exclusively in Life Sciences she specialises in C-level appointments, senior scientific leadership and critical R&D hires, particularly for growth-stage and investor-backed companies. Her work connects leadership decisions with business strategy, helping companies strengthen their capabilities and deliver on investment priorities. She serves as Board Advisor to the Life Science Cluster Krakow and the Life Science Competence Board, contributing to strategic talent initiatives and cross-border collaboration across the European Life Sciences ecosystem.Read full bio →
• Izabela Najda-JędrzejewskaMinistry of Science and Higher EducationIzabela Najda-JędrzejewskaDeputy Director of the Department of Innovation and Development, Ministry of Science and Higher Education
• dr Maciej Wielochiif.VCdr Maciej WielochManaging Partner, iif.VCMaciej Wieloch, PhD, is actively involved in developing the venture capital market, supporting startups and innovative technology projects through investment and strategic advisory. He is Managing Partner of iif.vc and President of the Management Board (CEO) of infini ASI, as well as Assistant Professor at the Collegium of Management and Finance, SGH Warsaw School of Economics. He serves on several supervisory boards, including those of Vaxican, BioResearch Pharma and Fresh Inset.Read full bio →